Accession Number: | 0001562180-20-001799 |
Date: | 2020-02-25 |
Issuer: | AMARIN CORP PLC\UK (AMRN) |
Original Submission Date: |
KETCHUM STEVEN B
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER, NJ 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-02-25 | M | 25,974 | a | $0.00 | 514,074 | direct | ||
ORDINARY SHARES | 2020-02-25 | M | 25,974 | a | $0.00 | 540,048 | direct | ||
ORDINARY SHARES | 2020-02-25 | F | 25,586 | d | $17.58 | 514,462 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-02-25 | deemed execution date | A | 55,000 (a) | ordinary shares 55,000 | $0.00 | 55,000 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-02-25 | deemed execution date | M | 25,974 (d) | ordinary shares 25,974 | $0.00 | 29,026 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-02-25 | deemed execution date | A | 55,000 (a) | ordinary shares 55,000 | $0.00 | 55,000 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-02-25 | deemed execution date | M | 25,974 (d) | ordinary shares 25,974 | $0.00 | 29,026 | direct |
ID | footnote |
---|---|
f1 | the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share. |
f2 | on may 15, 2017, the reporting person was granted 220,000 restricted stock units ("rsus") under the amarin corporation plc 2011 stock incentive plan (the "plan"). these rsus consist of three tranches representing 25%, 25% and 50% of the total award. each tranche vests ratably over 36 months beginning sept. 30, 2018 subject to achievement of certain prespecified performance criteria and continued employment of the reporting person as provided in the rsu award agreement between the issuer and reporting person. on feb. 25, 2020, pursuant to reporting of audited net total revenue for 2019 exceeding $400 million, the performance criteria related to both 25% tranches was deemed to be achieved, resulting in the vesting of 25,974 rsus per tranche. the remaining rsus in these two tranches will continue to vest over 19 monthly installments. the performance criteria related to the 50% tranche has not yet been achieved; such tranche has not lapsed as a result of achieving the other two tranches. |
f3 | not applicable. |
f4 | represents withholding by the issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with rule 16b-3, and not a market sale of securities. |
f5 | please see the section titled "remarks" below for additional information. |
f6 | each rsu represents a contingent right to receive one ordinary share or cash in lieu thereof at the issuer's discretion. |